The investigators, Stephen A. Grupp, MD, PhD and Carl H. June, MD, engineered T cells - the workhorses of the immune system, which recognized and attack invading disease cells - to selectively kill another type of immune cell called B cells, which had become cancerous.
According to new research from The Children's Hospital of Philadelphia and the University of Pennsylvania,
